These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 34926586)

  • 1. Cytokines and Chemokines in HBV Infection.
    Zhong S; Zhang T; Tang L; Li Y
    Front Mol Biosci; 2021; 8():805625. PubMed ID: 34926586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiles of circulating cytokines, chemokines and immune cells in patients with hepatitis B virus infection.
    Lian JQ; Yang XF; Zhao RR; Zhao YY; Li Y; Zhang Y; Huang CX
    Hepat Mon; 2014 Jun; 14(6):e18892. PubMed ID: 24976843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B.
    Rinker F; Zimmer CL; Höner Zu Siederdissen C; Manns MP; Kraft ARM; Wedemeyer H; Björkström NK; Cornberg M
    J Hepatol; 2018 Sep; 69(3):584-593. PubMed ID: 29758333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL13-mediated recruitment of intrahepatic CXCR5
    Li Y; Tang L; Guo L; Chen C; Gu S; Zhou Y; Ye G; Li X; Wang W; Liao X; Wang Y; Peng X; Liu G; Zhang X; Sun J; Peng J; Hou J
    J Hepatol; 2020 Mar; 72(3):420-430. PubMed ID: 31610223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections.
    Li X; Liu X; Tian L; Chen Y
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):41-54. PubMed ID: 25480494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues.
    Rapti I; Hadziyannis S
    World J Hepatol; 2015 May; 7(8):1064-73. PubMed ID: 26052395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches.
    Fisicaro P; Barili V; Rossi M; Montali I; Vecchi A; Acerbi G; Laccabue D; Zecca A; Penna A; Missale G; Ferrari C; Boni C
    Front Immunol; 2020; 11():849. PubMed ID: 32477347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell therapy for chronic viral hepatitis.
    Bertoletti A; Tan AT; Koh S
    Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on hepatitis B virus infection.
    You CR; Lee SW; Jang JW; Yoon SK
    World J Gastroenterol; 2014 Oct; 20(37):13293-305. PubMed ID: 25309066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention: Lessons learned from nucleos(t)ide analogues therapy.
    Tavakolpour S; Mirsafaei HS; Elkaei Behjati S; Ghasemiadl M; Akhlaghdoust M; Sali S
    Immunol Lett; 2017 Oct; 190():206-212. PubMed ID: 28827021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antiviral therapy on the cellular immune response in patients with chronic hepatitis B.
    Luo G; Feng X; Huang Y; Yi T; Wang D; Guo X; Yan H; Zhang G
    Mol Med Rep; 2015 Feb; 11(2):1284-91. PubMed ID: 25371014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.
    Lebossé F; Testoni B; Fresquet J; Facchetti F; Galmozzi E; Fournier M; Hervieu V; Berthillon P; Berby F; Bordes I; Durantel D; Levrero M; Lampertico P; Zoulim F
    J Hepatol; 2017 May; 66(5):897-909. PubMed ID: 28043874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The balance of type 1 and type 2 immune responses in the contexts of hepatitis B infection and hepatitis D infection.
    Townsend EC; Zhang GY; Ali R; Firke M; Moon MS; Han MAT; Fram B; Glenn JS; Kleiner DE; Koh C; Heller T
    J Gastroenterol Hepatol; 2019 Apr; 34(4):764-775. PubMed ID: 30695096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B.
    Kennedy PTF; Sandalova E; Jo J; Gill U; Ushiro-Lumb I; Tan AT; Naik S; Foster GR; Bertoletti A
    Gastroenterology; 2012 Sep; 143(3):637-645. PubMed ID: 22710188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Proinflammatory Cytokine Production by Chronic Hepatitis B Patients with Mutant Hepatitis B Virus: Plausible Mechanisms Underlying Severe Liver Diseases in These Patients.
    Raihan R; Akbar SMF; Al Mahtab M; Khan MSI; Tabassum S; Tee KK; Mohamed RB
    Viral Immunol; 2020 Sep; 33(7):530-534. PubMed ID: 32513066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression.
    Khanam A; Chua JV; Kottilil S
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of 10 circulating cytokines/chemokines in HBV-related liver disease.
    Jia Y; Jiao X; Shi W; Luo Y; Xiang H; Liang J; Gao Y
    Infect Agent Cancer; 2024 May; 19(1):20. PubMed ID: 38693593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
    Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C
    Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8
    Nandi M; Pal S; Ghosh S; Chakraborty BC; Dey D; Baidya A; Shil A; Chattopadhyaya S; Banerjee S; Santra A; Chowdhury A; Datta S
    Clin Sci (Lond); 2019 Sep; 133(17):1917-1934. PubMed ID: 31477625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune regulation and viral diversity as correlates of natural and treatment induced immune control in persistent hepatitis B virus (HBV) infection.
    Parfieniuk-Kowerda A; Jaroszewicz J; Flisiak R
    Clin Exp Hepatol; 2015 Jun; 1(2):35-38. PubMed ID: 28856253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.